CHRISTOPHER P. LOWE
CIK 1376260 · Interim CEO, COO & CFO · last filed 2022-08-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$508
Companies
5
Total Filings
47
Lifetime Open-Market Net
-$3.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VINC | Director | 40,000 | $0.01 | $508 | $175.6K | 4 | 2022-08-26 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Interim CEO, COO & CFO | 265,000 | $1.95 | $516.8K | -$3.67M | 10 | 2022-03-04 |
| Vincerx Pharma, Inc. (VINCW) Delisted | Director | — | $1.61 | — | $0 | 1 | 2020-12-28 |
| HANSEN MEDICAL INC (HNSN) Delisted | Interim CFO | 22,500 | — | — | $45.6K | 12 | 2016-02-04 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | CFO and Chief Business Officer | 108,915 | — | — | -$367.0K | 19 | 2013-05-21 |
Recent Filings · Page 3 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-21 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-15 | HANSEN MEDICAL INC (HNSN) Delisted | Buy (P) | +12,500 | $19.0K | EDGAR |
| 2013-03-27 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | +67,579 | $0 | EDGAR |
| 2013-01-07 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Tax (F) | −8,660 | -$6.0K | EDGAR |
| 2012-05-30 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-03 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-02-06 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | +18,845 | $0 | EDGAR |
| 2012-02-03 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −15,000 | -$114.9K | EDGAR |
| 2011-11-04 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −15,000 | -$103.2K | EDGAR |
| 2011-10-27 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −4,637 | -$32.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.